布鲁克公司（Bruker Corp）在一份提交给美国证券交易委员会（SEC）的文件中表示，预计到2026年，其非GAAP每股收益（EPS）将实现两位数增长。该文件还对之前版本中遗漏的句号进行了修正。
这一预期反映了公司在科学仪器领域的持续创新和市场扩张战略。布鲁克专注于生命科学、材料研究和临床诊断等高增长领域，通过技术升级和全球业务布局推动盈利能力的提升。
非GAAP每股收益指标排除了某些非经常性项目的影响，能更清晰地展现公司核心业务的增长趋势。分析人士指出，这一目标若实现，将显著增强投资者对布鲁克长期盈利能力的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.